New antibody-drug conjugate shows early promise against all forms of melanoma

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Immunotherapy in melanoma

AG-221 shows clinical activity in acute myeloid leukaemia

Impact of the liver environment upon the efficacy of induction therapy

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor

Effective use of ibrutinib in the treatment of ABC lymphoma tumours

New drug demonstrates early promise in metastatic breast cancer

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment